Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-26 @ 1:47 AM
Study NCT ID:
NCT05138133
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2021-11-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-17
First Submit QC Date:
None
Study First Post Date:
2021-11-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-16
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED